Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits [Arrhythmia and Electrophysiology]

ConclusionsDipeptidyl peptidase‐4 inhibitors can prevent atrial fibrillation by reversing electrophysiological abnormalities, improving mitochondrial function, and promoting mitochondrial biogenesis.

Source: JAHA:Journal of the American Heart Association - May 15, 2017 Category: Cardiology Authors: Zhang, X., Zhang, Z., Zhao, Y., Jiang, N., Qiu, J., Yang, Y., Li, J., Liang, X., Wang, X., Tse, G., Li, G., Liu, T. Tags: Arrhythmias, Electrophysiology Original Research Source Type: research